Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review

Published:2021-06-07 Issue: Volume:22 Page:
ISSN:1941-5923
Container-title:American Journal of Case Reports
language:en
Short-container-title:Am J Case Rep

Author:

Hinata Yudai¹,Ohara Nobumasa¹,Sakurai Yuhki¹,Koda Ryo²,Yoneoka Yuichiro³,Takada Toshinori⁴,Hara Noboru⁵,Nishiyama Tsutomu⁵

Affiliation:

1. Department of Endocrinology and Metabolism, Uonuma Kikan Hospital, Minamiuonuma, Niigata, Japan

2. Department of Nephrology, Uonuma Kikan Hospital, Minamiuonuma, Niigata, Japan

3. Department of Neurosurgery, Uonuma Kikan Hospital, Minamiuonuma, Niigata, Japan

4. Department of Respiratory Medicine, Uonuma Kikan Hospital, Minamiuonuma, Niigata, Japan

5. Department of Urology, Uonuma Kikan Hospital, Minamiuonuma, Niigata, Japan

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-1/PD-L1 inhibitors associated hypophysitis: An analysis from the FAERS database and case reports;Drug Discoveries & Therapeutics;2024-02-29

2. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report;Journal of Pharmaceutical Health Care and Sciences;2024-02-16

3. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review;Frontiers in Endocrinology;2024-01-22

4. Diagnostic strategies in adrenal insufficiency;Current Opinion in Endocrinology, Diabetes & Obesity;2023-04-07

5. Machine Learning Models Using Routinely Collected Clinical Data Offer Robust and Interpretable Predictions of 90-Day Unplanned Acute Care Use for Cancer Immunotherapy Patients;JCO Clinical Cancer Informatics;2023-03